DUSP4 and breast carcinoma: Arteaga and colleagues found that loss of dual specificity phosphatase-4 (DUSP4), a negative regulator of the MAPK pathway, promoted cancer stem cell-like phenotypes in basal-like breast cancer (Balko et al., 2013).